Articles P7340
Turning Conflict into Cooperation
The Rainforest Action Network launched a consumer boycott of several Mitsubishi companies, leading to significant changes in the way the firm and many of its partners do business.
Reshaping Social Entrepreneurship
By focusing so much attention on the social entrepreneur we fail to recognize the thousands of others who are crafting solutions to pressing problems.
Drowning in Data
Funders are calling for more program evaluation, but nonprofits are often collecting dubious data, at great cost to themselves and ultimately to the people they serve.
The Other CSR
Consumers say they want to buy green products but they don't always follow through. There are, however, strategies corporations can take to increase sales of sustainable goods.
A New Take on Tithing
Too often, individuals make decisions about how much money to donate to charitable causes on an ad hoc basis. As a result, many people give less money than they can actually afford.
Podcast
Expecting Returns - Bridging the Gap Conference
For years, many believed that socially responsible investments could simply not hold up to traditional investments. In this panel discussion from the Stanford 2005 Net Impact Conference, organized by the Stanford Business School, social capital market experts dispel the myths associated with socially responsible investing, and look toward the future of what is to come as more and more funds offer social choices.
Podcast
Kent Thiry - From Demoralization to Living Community
DaVita is the largest independent provider in the United States of dialysis services to people with chronic kidney failure. In 2000, DaVita was being investigated by the SEC and sued by shareholders. In this audio lecture recorded at Bridging the Gap, the Stanford 2005 Net Impact conference, Kent Thiry explains how building community and shared values bumped DaVita's market capitalization to $3 billion and turned it into a leader in its field.
Podcast
Robert Langer - The Promise of Biomedical Engineering
Robert Langer has been referred to as "a medical pioneer in the guise of an engineer" who has revolutionized the delivery of drugs and the engineering of human tissue. In this audio interview with Globeshakers host Tim Zak, Langer reveals his tenacious nature and talks about what it takes to persevere in the face of public criticism.